Live·Open questions in longevity research
All news
Longevity research

Sarcopenia should be viewed as a disease of the aging motor system

3 September 2026· 260903002

Sarcopenia should be viewed as a disease of the aging motor system

On August 28, The Lancet Healthy Longevity published an article on age-related loss of strength and mobility. The authors propose looking for causes along the entire motor pathway, from the brain and spinal cord to the peripheral nerves, neuromuscular junctions, and muscles.

When a person rises from a chair or maintains balance, the brain sends signals through the spinal cord and the nerves that connect to the muscles. At the point where a nerve connects with a muscle, the signal triggers muscle fiber contraction. The force and speed of movement depend on the muscle itself, which fibers are recruited, how frequently nerve impulses arrive, and how reliably the signal reaches the muscle.

This explains why people with similar muscle mass may differ in their ability to walk, climb stairs, and remain stable. In clinical trials, drugs have increased muscle mass, but their effects on movement have varied. Exercise can improve strength, power, and mobility without a measurable change in muscle mass. Current diagnostic criteria for sarcopenia already assess strength and physical performance alongside muscle characteristics. The authors propose investigating the causes of these measures across the entire motor pathway.

The authors propose a two-step assessment. First, a clinician evaluates strength, gait, balance, coordination, sensation, reflexes, and the rate at which the person develops force. If the limiting part of the motor pathway must then be identified, specialists can record the electrical activity of the muscles. They can also estimate the number of motor units, each of which consists of a nerve cell and the muscle fibers it controls. Separate tests assess how well a nerve conducts a signal and transmits it to the muscle. These measurements can identify the part of the pathway that most strongly limits movement in a particular person or group.

In future trials, the authors propose grouping participants according to the underlying mechanism and measuring strength, power, gait, and balance. This approach would test whether a specific intervention helps people whose loss of strength has different causes and whether the benefit translates into improved movement.

Originally published on Telegram by Ukhvat NewsView on Telegram
Sources
#sarcopenia#motor-system#muscle-strength#neuromuscular-junction#mobility#aging